WHAT WE DO
We are a global company
Since the first moment, we positioned ourselves as worldwide advisory experts, covering all startup subjects and specialized on the healthcare sector.
We can equip certain talented startups with the right tools to achieve a successful exit, just like we did. ”
Diogo R. Anjos
CEO
OUR services
What Make Us Different
There are multiple dimensions that a successful healthcare startup must tackle simultaneously.
IP
Where to deploy your patents. When to do it. How to do it. With whom.
Regulatory
Introduce regulatory requirements into your R&D pipeline. Scientific Advice and Protocol Assistance guidance, amongst others.
Team
Maximize the odds of having the right team at the right time. Secure the scientific and management experts you need.
Fundraising
Equity&non-dilutive rounds, convertible notes&SAFEs, bridge loans, capital leveraging, SPA, LOI, TermSheets, Warrants. We have done it all.
Services
A Mission
to help mankind.
>40 Patents
granted
00x Multiple
Exit
+1000
pitches
Who we are and what we do
Tzientzia is a spinoff of the first Portuguese successful exit startup Lymphact.
On the investment front, we collaborated with leading global funds, including Orbimed, Versant Ventures, Celgene, Gilde Healthcare, Sanofi Investments, and many others.
In 2018, we were acquired by Takeda Pharmaceuticals through a London-based entity, Gamma Delta Therapeutics, as part of a fully executed three-year rollout contract.
We now share this expertise with talented startups facing similar challenges, whether related to investment, scaling, regulatory matters, intellectual property, team building, or any other area. These services may include:
Technology transfer guidance to navigate collaborations with universities, research hospitals, or IP offices
Preclinical and Phase I planning outlining regulatory requirements and timelines
Pitch deck development and coaching, from refining your narrative to preparing for tough investor questions
Fractional C-suite leadership (CEO, CSO, CBO) for startups that need executive-level direction without full-time overhead
Board-level strategy support to help guide long-term decisions, partner negotiations, and major milestones